August 29th 2025
Your daily dose of the clinical news you may have missed.
August 15th 2025
The US FDA approved Tonmya, a groundbreaking treatment for fibromyalgia, offering hope to millions experiencing chronic pain and sleep issues.
January 2nd 2025
NX-102 SL is a non-opioid, centrally acting analgesic, granted Fast Track designation by FDA.
December 17th 2024
If approved, the nonopioid, centrally acting analgesic would be the first in a new class of medications for fibromyalgia in more than 15 years, Tonix said.
May 18th 2023
Your daily dose of clinical news you may have missed.